"Immunotherapy strategies" refers to different approaches or techniques that use the body's immune system to fight diseases like cancer or infections. These strategies aim to boost or manipulate the body's natural defense mechanisms to recognize and attack harmful cells.
Full definition
The researchers are developing a potential
new immunotherapy strategy for melanoma based on their insights into Autoimmune Polyendocrinopathy Type 1, a rare, inherited disorder in which T - cells attack healthy cells and tissues.
The results show that generation of an optimal immune response to cancer requires cooperation between two types of memory T cell — one circulating in the blood and the other resident in tissues — that can be reactivated with
current immunotherapy strategies.
Building on clinical data from several single - agent immunotherapy clinical trials, and by engaging scientists with unique and complementary expertise from eight institutions and three industry partners, the BEAT - HIV Collaboratory's central mission will be to develop and test innovative
combined immunotherapy strategies to eradicate and / or permanently suppress HIV replication in the absence of ART.
This treatment represents a second generation approach to the same telomerase loaded, dendritic cell
vaccination immunotherapy strategy that has been tested in two previous clinical trials of our AST - VAC1 product.
Their work encompasses several strategies, including: developing FL - HCC animal models to characterize tumor - immune interactions, exploring if a mutated protein associated with FL - HCC could be targeted by immunotherapy, identifying immune checkpoints that could potentially serve as targets for immunotherapy as well as biomarkers for analyzing patients, and evaluating the effectiveness
of immunotherapy strategies against FL - HCC patient samples in the lab.
These results, published in Nature Communications, have the potential to improve current
cancer immunotherapy strategies, especially in relation to the prevention of metastasis (dissemination of the tumor to organs distant from the site of origin).
Conversely, Carl Ware, Ph.D., professor and director of the Infectious and Inflammatory Diseases Center, is developing
an immunotherapy strategy that's the equivalent of «hitting the gas» to expand anti-tumor responses.
We're solving common treatment problems using unique targeted therapy and
immunotherapy strategies.